参考文献
[1] Lopez MC, Silva Y, Thomas MC, et al. Characterization of the chimeric SPf(66)n molecule used as a vaccine against malaria [J]. Vaccine, 1994, 12:585-591
[2] Francis M J, Fry CM, Rowlands DJ, et al. Immunological Priming with Synthetic Peptides of Foot-and-Mouth Disease virus [J]. J. Gen. Virol, 1985, 66:2347-2354.
[3] Francis MJ, Fry CM, Rowlands DJ,et al. Immune response to uncoupled peptides of foot-and-mouth disease virus [J]. Immunology, 1987, 61(1):1-6.
[4] DiMarchi R, Brooke G, Gale C, et al. Protection of cattle against foot-and-mouth disease by a synthetic peptide [J]. Science, 1986, 232:639-641.
[5] Doel TR, Gale C, Brooke G, et al. Immunization against foot-and-mouth disease with synthetic peptides representing the C-terminal region of VP1 [J]. J. Gen. Virol, 1988, 69:2403-2406.
[6] Steward MW, Stanley CM, DiMarchi R, et al. High-affinity antibody induced by immunization with a synthetic peptide is associated with protection of cattle against foot-and-mouth disease [J]. Immunology, 1991, 72:99-103.
[7] Francis MJ, Hastings GZ, Brown F, et al. Immunological evaluation of the multiple antigen peptide (MAP) system using the major immunogenic site of foot-and-mouth disease virus [J]. Immunology, 1991, 73:249-254.
[8] Zamorano P, Wigdorovitz A, Perez-filgueira M, et al. A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice [J].Virology,1995,212:614-621.
[9] Zamorano P I, Wigdorovitz A, Perez Filgueira DM, et al. Induction of anti foot and mouth disease virus T and B cell responses in cattle immunized with a peptide representing ten amino acids of VP1 [J].Vaccine,1997,16(6):558-563.
[10] Benkirane N, Guichard G, Briand JP, et al. Mimicry of viral epitopes with retro-inverso peptides of increased stability [J].Dev Biol Stand, 1996, 87:283-291.
[11] Brown F. Use of peptides for immunization against foot-and-mouth disease [J]. Vaccine, 1988, 6(2):180-182.
[12] Doel TR, Gale C, Do Amaral CMC F, et al. Heterotypic protection induced by synthetic peptides corresponding to three serotypes of foot-and-mouth disease virus [J]. J Virol, 1990,64:2260-2264.
[13] Wang CY, Chang TY, AM Walfield, et al. Effective synthetic peptide vaccine for foot-and-mouth disease in swine [J]. Vaccine, 2002, 20:2603-2610.
[14] Wang, JL, Liu MQ, Han J, et al, A peptide of foot-and-mouth disease virus serotype Asia1 generating a neutralizing antibody response, and an immunostimulatory peptide [J]. Vet. Microbiol, 2007,125(3-4):224-231.
[15] Beignon AS, Brown F, Eftekhari P, et al. A peptide vaccine administered transcutaneously together with cholera toxin elicits potent neutralising anti-FMDVantibody responses [J]. Vet Immunol Immunopathol,2005,104:273-280.
[16] Su CX, Duan XG, Wang XQ, et al. Heterologous expression of FMDVimmunodominant epitopes and HSP70 in P. pastoris and the subsequent immune response in mice [J]. Vet Microbiol, 2007,124:256-263.
[17] Zhang YL, Guo YJ, Wang KY, et al. Enhanced Immunogenicity of Modified Hepatitis B Virus Core Particle Fused with Multiepitopes of Foot-and-Mouth Disease Virus [J]. Scand J Immunol,2007,65(4):320-328.
[18] Gerner W, Carr BV, Wiesmuller KH, et al. Identification of a novel foot-and-mouth disease virus specific T-cell epitope with immunodominant characteristics in cattle with MHC serotype A31 [J].Vet. Res,2007,38:565-572.
[19] Du YJ, LiYF, He HR, et al. Enhanced immunogenicity of multiple-epitopes of foot-and-mouth disease virus fused with porcine interferon аin mice and protective efficacy in guinea pigs and swine [J]. J Virol Methods,2008,149 :144-152.
[20] Cubillos C. de la Torre BG, Jakab A, et al. Enhanced Mucosal Immunoglobulin A Response and Solid Protection against Foot-and-Mouth Disease Virus Challenge Induced by a Novel Dendrimeric Peptide [J].J Virol, 2008, 82:7223-7230.
[21] Greenwood DLV, Dynon K, Kalkanidis M, et al. Vaccination against foot-and-mouth disease virus using peptides conjugated to nano-beads [J].Vaccine,2008,26:2706-2713.
|
